The trademark application MYMAB was filed by UCB Biopharma SRL, a corporation established under the laws of the Kingdom of Belgium (the "Applicant"). Application withdrawn.
The application was filed in English (German was selected as the second language).
The Refusal with reference B 018219485 was Rejected according to Article 7(1)(b) EUTMR with decision issued on October 6, 2020 by the EUIPO.